Scintica & Trust Bio-sonics
Scintica and Trust Bio-sonics announce exclusive partnership for the distribution of its preclinical USphere™ Series Contrast Agents [January 27, 2022] Scintica is excited to announce its exclusive distribution agreement for North America and Europe with Trust Bio-sonics, a pharmaceutical company and developer of the USphere Series of contrast agents for translational research and medicine